GSK Expands Share Buyback, Lifts Treasury Holding to 6.41% of Voting Rights

GSK has repurchased 330,000 ordinary shares on April 20, 2026, as part of its ongoing share buyback program, bringing its treasury holdings to 6.41% of voting rights. Since the program began in February 2026, GSK has acquired over 20 million shares, signaling a focus on shareholder returns and balance sheet flexibility. TipRanks’ AI Analyst, Spark, rates GSK as Neutral due to strong profitability and reasonable valuation, tempered by technical overbought risk.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin